← Leaderboards
Glen N. Barber
University Of Miami School Of Medicine
$22,145,694
Attributed
$22,690,723
Total exposure
15
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,274,894 · 16
By mechanism
R01$17,778,864 · 10
P01$7,881,591 · 3
U01$1,813,573 · 1
R21$417,116 · 1
R56$383,750 · 1
Top collaborators
- Sergio C Oliveira5 shared
- Judith Anne Smith5 shared
- Gary A Splitter5 shared
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- William J Harrington$5,964,578
Others in their field
Top investigators on “Interferons”
- Norman Wolmark · Nsabp Foundation, Inc.$62,740,119
- Kent J. Weinhold · Duke University$39,902,311
- Michael J Gale · University Of Texas Sw Med Ctr/Dallas$39,525,737
- Charles M. Rice · Rockefeller University$34,398,649
- Luis J. Montaner · Wistar Institute$32,339,250
- Lionel B Ivashkiv · Hospital For Special Surgery$29,564,114
Research focus
InterferonsMediatingViralImmune ResponsePathway InteractionsImmuneResponseCellsInfectionProductionHost DefenseGenesReceptorInterferon Type IRegulationProteinsVirusProtein KinasePathogenDesignTumorReportingSignal TransductionTranscription Factor
Grant awards (79)
Development of A HTLV-1 Vaccine$601,378
R01 · FY2025 · CA · contact PI
Brucella induces STING-mediated Guanylate-Binding Protein expression and Unfolded Protein Response: Balancing Bacterial Elimination, Inflammation and Disease$144,587
R01 · FY2025 · AI
Development of A HTLV-1 Vaccine$561,036
R01 · FY2024 · CA · contact PI
Brucella induces STING-mediated Guanylate-Binding Protein expression and Unfolded Protein Response: Balancing Bacterial Elimination, Inflammation and Disease$144,676
R01 · FY2024 · AI
Development of A HTLV-1 Vaccine$583,747
R01 · FY2023 · CA · contact PI
Brucella induces STING-mediated Guanylate-Binding Protein expression and Unfolded Protein Response: Balancing Bacterial Elimination, Inflammation and Disease$144,760
R01 · FY2023 · AI
Development of A HTLV-1 Vaccine$588,742
R01 · FY2022 · CA · contact PI
Brucella induces STING-mediated Guanylate-Binding Protein expression and Unfolded Protein Response: Balancing Bacterial Elimination, Inflammation and Disease$144,909
R01 · FY2022 · AI
Development of A HTLV-1 Vaccine$623,689
R01 · FY2021 · CA · contact PI
Brucella induces STING-mediated Guanylate-Binding Protein expression and Unfolded Protein Response: Balancing Bacterial Elimination, Inflammation and Disease$147,774
R01 · FY2021 · AI
The Role of STING in Innate Immunity$422,604
R01 · FY2019 · AI · contact PI
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells$324,863
R01 · FY2019 · CA · contact PI
The Role of STING in Innate Immunity$422,604
R01 · FY2018 · AI · contact PI
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells$334,911
R01 · FY2018 · CA · contact PI
The Role of STING in Innate Immunity$588,686
R01 · FY2017 · AI · contact PI
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells$332,363
R01 · FY2017 · CA · contact PI
The Role of STING in Innate Immunity$476,941
R01 · FY2016 · AI · contact PI
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells$332,363
R01 · FY2016 · CA · contact PI
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells$332,363
R01 · FY2015 · CA · contact PI
The Role of STING in Innate Immunity$133,256
R01 · FY2015 · AI · contact PI
The role of STING in innate immunity$383,750
R56 · FY2014 · AI · contact PI
Host Defense Regulation and Viral Oncogenesis$1,044,934
P01 · FY2013 · CA · contact PI
Evaluation of Novel DExD/H Helicases in Innate Immune Signaling$344,830
U01 · FY2013 · AI · contact PI
Regulation of Innate Immune Responses$275,273
P01 · FY2013 · CA · contact PI
Administration Core$154,161
P01 · FY2013 · CA · contact PI
Host Defense Regulation and Viral Oncogenesis$1,103,015
P01 · FY2012 · CA · contact PI
Host Defense and the Regulation of Interferon Production$374,888
R01 · FY2012 · AI · contact PI
Evaluation of Novel DExD/H Helicases in Innate Immune Signaling$366,840
U01 · FY2012 · AI · contact PI
Regulation of Innate Immune Responses$293,992
P01 · FY2012 · CA · contact PI
Administration Core$164,555
P01 · FY2012 · CA · contact PI
Host Defense Regulation and Viral Oncogenesis$1,107,550
P01 · FY2011 · CA · contact PI
Host Defense and the Regulation of Interferon Production$374,888
R01 · FY2011 · AI · contact PI
Evaluation of Novel DExD/H Helicases in Innate Immune Signaling$367,148
U01 · FY2011 · AI · contact PI
Regulation of Innate Immune Responses$291,677
P01 · FY2011 · CA · contact PI
Administration Core$163,168
P01 · FY2011 · CA · contact PI
Host Defense Regulation and Viral Oncogenesis$1,166,688
P01 · FY2010 · CA · contact PI
Host Defense and the Regulation of Interferon Production$378,675
R01 · FY2010 · AI · contact PI
Evaluation of Novel DExD/H Helicases in Innate Immune Signaling$370,840
U01 · FY2010 · AI · contact PI
Regulation of Innate Immune Responses$307,202
P01 · FY2010 · CA · contact PI
Mechanisms of VSV-Mediated Oncolysis$299,221
R01 · FY2010 · CA · contact PI
Targeted Therapy for Burkitt Lymphoma in Resource Poor Settings$248,486
R01 · FY2010 · CA · contact PI
Administration Core$171,754
P01 · FY2010 · CA · contact PI
Innate Intracellular Mechanisms$126,225
R01 · FY2010 · AI · contact PI
Host Defense Regulation and Viral Oncogenesis$1,161,984
P01 · FY2009 · CA · contact PI
Host Defense and the Regulation of Interferon Production$382,500
R01 · FY2009 · AI · contact PI
Evaluation of Novel DExD/H Helicases in Innate Immune Signaling$363,915
U01 · FY2009 · AI · contact PI
Regulation of Innate Immune Responses$304,967
P01 · FY2009 · CA · contact PI
Mechanisms of VSV-Mediated Oncolysis$299,221
R01 · FY2009 · CA · contact PI
Targeted Therapy for Burkitt Lymphoma in Resource Poor Settings$248,486
R01 · FY2009 · CA · contact PI
Administration Core$170,671
P01 · FY2009 · CA · contact PI
Innate Intracellular Mechanisms$126,225
R01 · FY2009 · AI · contact PI
Host Defense and the Regulation of Interferon Production$382,500
R01 · FY2008 · AI · contact PI
Role of PKR in Growth Regulation$323,212
R01 · FY2008 · CA · contact PI
Targeted Therapy for Burkitt Lymphoma in Resource Poor Settings$248,486
R01 · FY2008 · CA · contact PI
A FADD-Associated Helicase Essential for Host Defense$187,616
R21 · FY2008 · AI · contact PI
Role of PKR in Growth Regulation$323,212
R01 · FY2007 · CA · contact PI
Mechanisms of Vesicular Stomatitis Virus-mediated Oncolysis$287,658
R01 · FY2007 · CA · contact PI
Immunogenicity of Hepatitis C Virus (HCV) like particles$287,299
R01 · FY2007 · AI · contact PI
A FADD-Associated Helicase Essential for Host Defense$229,500
R21 · FY2007 · AI · contact PI
Role of PKR in Growth Regulation$332,865
R01 · FY2006 · CA · contact PI
Mechanisms of VSV-mediated Oncolysis$296,249
R01 · FY2006 · CA · contact PI
Immunogenicity of Hepatitis C Virus (HCV) like particles$295,880
R01 · FY2006 · AI · contact PI
Role of PKR in Growth Regulation$340,875
R01 · FY2005 · CA
Mechanisms of VSV-mediated Oncolysis$303,379
R01 · FY2005 · CA
Immunogenicity of Hepatitis C Virus (HCV) like particles$303,000
R01 · FY2005 · AI
Role of PKR in Growth Regulation$340,875
R01 · FY2004 · CA
Mechanisms of VSV-mediated Oncolysis$303,379
R01 · FY2004 · CA
Immunogenicity of Hepatitis C Virus (HCV) like particles$303,000
R01 · FY2004 · AI
FUNCTION ANALYSIS OF THE DSRNA REGULATED NUCLEAR FACTORS$232,269
R01 · FY2004 · CA
ROLE OF PKR IN GROWTH REGULATION AND APOPTOSIS$330,309
R01 · FY2003 · CA
Mechanisms of VSV-mediated Oncolysis$303,379
R01 · FY2003 · CA
FUNCTION ANALYSIS OF THE DSRNA REGULATED NUCLEAR FACTORS$226,881
R01 · FY2003 · CA
Immunogenicity of Hepatitis C Virus (HCV) like particles$151,500
R01 · FY2003 · AI
ROLE OF PKR IN GROWTH REGULATION AND APOPTOSIS$321,075
R01 · FY2002 · CA
FUNCTION ANALYSIS OF THE DSRNA REGULATED NUCLEAR FACTORS$221,649
R01 · FY2002 · CA
ROLE OF PKR IN GROWTH REGULATION AND APOPTOSIS$315,261
R01 · FY2001 · CA
FUNCTION ANALYSIS OF THE DSRNA REGULATED NUCLEAR FACTORS$216,569
R01 · FY2001 · CA
ROLE OF PKR IN GROWTH REGULATION AND APOPTOSIS$318,438
R01 · FY2000 · CA
FUNCTION ANALYSIS OF THE DSRNA REGULATED NUCLEAR FACTORS$224,598
R01 · FY2000 · CA